{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:52:34Z","timestamp":1772160754998,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Peyronie's disease (PD) has frequently been associated with erectile dysfunction (ED) and may further compromise coitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate the efficacy of intratunical injection of genetically modified rat adipose tissue-derived stem cells (ADSCs) expressing human interferon \u03b1-2b (ADSCs-IFN) in decreasing fibrosis and restoring erectile function in a rat model of tunica albugineal fibrosis (TAF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 36 Sprague-Dawley rats (12 weeks old; 300\u2013350 g) were randomly divided in six equal groups: (i) sham group (50 \u03bcL saline-injected into the tunica albuginea [TA]); (ii) TAF group (transforming growth factor [TGF]-\u03b21 [0.5 \u03bcg\/50 \u03bcL] injected into the TA); (iii) TGF-\u03b21 plus 5 \u00d7 105 control ADSCs injected same day; (iv) TGF-\u03b21 plus 5 \u00d7 105 ADSCs-IFN injected same day; (v) TGF-\u03b21 plus 5 \u00d7 105 control ADSCs injected after 30 days; and (vi) TGF-\u03b21 plus 5 \u00d7 105 ADSCs-IFN injected after 30 days. Rat allogeneic ADSCs were harvested from inguinal fat tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Forty-five days following the TGF-\u03b21 injection, erectile function was assessed, and penile tissues were harvested for further evaluations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the same-day injection groups, intratunical injection of ADSCs and ADSC-IFN improved erectile response observed upon stimulation of cavernous nerve compared with TAF group. Intratunical ADSC-IFN injection at day 30 improved erectile responses 3.1, 1.8, and 1.3 fold at voltages of 2.5, 5.0, and 7.0, respectively, when compared with TAF group. Furthermore, at voltages of 2.5 and 5.0, treatment on day 30 with ADSCs-IFN improved erectile responses 1.6- and 1.3-fold over treatment with ADSCs alone. Local injection of ADSCs or ADSCs-IFN reduced Peyronie's-like manifestations, and these effects might be associated with a decrease in the expression of tissue inhibitors of metalloproteinases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study documents that transplantation of genetically modified ADSCs, with or without human IFN \u03b1-2b, attenuated Peyronie's-like changes and enhanced erectile function in a rat model of TAF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jsm.12916","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T04:30:10Z","timestamp":1433997010000},"page":"1533-1544","source":"Crossref","is-referenced-by-count":48,"title":["Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon \u03b1-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis"],"prefix":"10.1093","volume":"12","author":[{"given":"Ahmet","family":"Gokce","sequence":"first","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"},{"name":"Department of Urology , Sakarya, \u00a0 Turkey"},{"name":"Sakarya University School of Medicine , Sakarya, \u00a0 Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakaria Y.","family":"Abd Elmageed","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George F.","family":"Lasker","sequence":"additional","affiliation":[{"name":"Department of Pharmacology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Bouljihad","sequence":"additional","affiliation":[{"name":"Tulane National Primate Research Center , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Braun","sequence":"additional","affiliation":[{"name":"Tulane National Primate Research Center , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hogyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Kadowitz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim B.","family":"Abdel-Mageed","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh C.","family":"Sikka","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne J.","family":"Hellstrom","sequence":"additional","affiliation":[{"name":"Department of Urology , New Orleans, LA , USA"},{"name":"Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"key":"2023010713352299000_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/j.1939-4640.2000.tb03387.x","article-title":"Peyronie's disease: Etiology, medical, and surgical therapy","volume":"21","author":"Hellstrom","year":"2000","journal-title":"J Androl"},{"key":"2023010713352299000_bb0015","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"2023010713352299000_bb0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ijir.2011.36","article-title":"Rat as an animal model for Peyronie's disease research: A review of current methods and the peer-reviewed literature","volume":"23","author":"Chung","year":"2011","journal-title":"Int J Impot Res"},{"key":"2023010713352299000_bb0025","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","article-title":"An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"key":"2023010713352299000_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijir.2011.45","article-title":"Review of non-surgical treatment options for Peyronie's disease","volume":"24","author":"Larsen","year":"2012","journal-title":"Int J Impot Res"},{"key":"2023010713352299000_bb0035","first-page":"17","article-title":"Current and emerging treatment options for Peyronie's disease","volume":"5","author":"Gokce","year":"2013","journal-title":"Res Rep Urol"},{"key":"2023010713352299000_bb0040","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1111\/j.1743-6109.2010.01875.x","article-title":"Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury","volume":"7","author":"Albersen","year":"2010","journal-title":"J Sex Med"},{"key":"2023010713352299000_bb0045","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/scd.2008.0117","article-title":"Defining stem and progenitor cells within adipose tissue","volume":"17","author":"Lin","year":"2008","journal-title":"Stem Cells Dev"},{"key":"2023010713352299000_bb0050","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/stem.169","article-title":"Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction","volume":"27","author":"Mias","year":"2009","journal-title":"Stem Cells"},{"key":"2023010713352299000_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2353\/ajpath.2009.080629","article-title":"Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury","volume":"175","author":"Moodley","year":"2009","journal-title":"Am J Pathol"},{"key":"2023010713352299000_bb0060","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3727\/096368912X640448","article-title":"Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats","volume":"21","author":"Alfarano","year":"2012","journal-title":"Cell Transplant"},{"key":"2023010713352299000_bb0065","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3748\/wjg.v18.i10.1048","article-title":"Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis","volume":"18","author":"Zhao","year":"2012","journal-title":"World J Gastroenterol"},{"key":"2023010713352299000_bb0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.2047-2927.2013.00181.x","article-title":"Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease","volume":"2","author":"Gokce","year":"2014","journal-title":"Andrology"},{"key":"2023010713352299000_bb0075","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"2023010713352299000_bb0080","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1073\/pnas.1113810109","article-title":"Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction","volume":"109","author":"Ma","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023010713352299000_bb0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cyto.b.20530","article-title":"Localization of CD44 and CD90 positive cells to the invasive front of breast tumors","volume":"78","author":"Donnenberg","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"2023010713352299000_bb0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/hum.2005.16.957","article-title":"Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition","volume":"16","author":"Indraccolo","year":"2005","journal-title":"Hum Gene Ther"},{"key":"2023010713352299000_bb0095","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1158\/0008-5472.CAN-07-6341","article-title":"The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects","volume":"68","author":"Moserle","year":"2008","journal-title":"Cancer Res"},{"key":"2023010713352299000_bb0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2012.09.034","article-title":"Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease","volume":"63","author":"Castiglione","year":"2013","journal-title":"Eur Urol"},{"key":"2023010713352299000_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/abio.2001.5099","article-title":"Heparin-enhanced zymographic detection of matrilysin and collagenases","volume":"293","author":"Yu","year":"2001","journal-title":"Anal Biochem"},{"key":"2023010713352299000_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/j.1939-4640.1999.tb02539.x","article-title":"A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease","volume":"20","author":"Ahuja","year":"1999","journal-title":"J Androl"},{"key":"2023010713352299000_bb0115","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"key":"2023010713352299000_bb0120","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1743-6109.2012.02827.x","article-title":"The therapeutic role of VEGF-expressing muscle-derived stem cells in acute penile cavernosal injury","volume":"9","author":"An","year":"2012","journal-title":"J Sex Med"},{"key":"2023010713352299000_bb0125","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1111\/j.1743-6109.2011.02454.x","article-title":"Characterization of erectile function in elastin haploinsufficicent mice","volume":"8","author":"Hidalgo-Tamola","year":"2011","journal-title":"J Sex Med"},{"key":"2023010713352299000_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5534\/wjmh.2013.31.3.183","article-title":"The non-surgical treatment of Peyronie disease: 2013 update","volume":"31","author":"Shaw","year":"2013","journal-title":"World J Mens Health"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515341576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515341576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/7\/1533\/48476073\/jsm_12_7_1533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/7\/1533\/48476073\/jsm_12_7_1533.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T08:57:34Z","timestamp":1717923454000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/12\/7\/1533\/6966825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,1]]},"published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12916","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725547313.793523281","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,7]]},"published":{"date-parts":[[2015,7,1]]}}}